Cite

HARVARD Citation

    Wang, Y. et al. (2020). Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial. Lancet. 395 (10236), pp. 1569-1578. [Online]. 
  
Back to record